Federal Court of Australia
FEDERAL COURT OF AUSTRALIA
Janssen Sciences Ireland UC v Alphapharm Pty Ltd [2017] FCA 1399 File number: NSD 1806 of 2017
Judge: YATES J
Date of judgment: 27 November 2017
Catchwords: PATENTS – threatened infringement – threatened PBS listing of generic pharmaceutical products – whether interim injunction should be granted – whether applicant has established prima facie case for final relief – consideration of challenge to validity of claims in suit – whether balance of convenience favours grant of interim relief – whether interim relief should be granted on terms
Legislation: National Health Act 1953 (Cth) s 85AD Patents Act 1990 (Cth) s 18
Cases cited: Apotex Pty Ltd v Warner-Lambert Co LLC [2016] FCA 1238; (2016) 122 IPR 17 Australian Broadcasting Corporation v Lenah Game Meats Pty Limited [2001] HCA 63; (2001) 208 CLR 199 Interpharma Pty Ltd v Commissioner of Patents [2008] FCA 1498; (2008) 79 IPR 261 Novartis AG v Hospira Pty Ltd (No 2) [2012] FCA 1113; (2012) 98 IPR 214 Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd [2012] FCA 239; (2012) 291 ALR 763 Samsung Electronics Co Limited v Apple Inc [2011] FCAFC 156 The General Tire & Company v The Firestone Tyre & Rubber Company Limited [1972] R.P.C. 457 Tire & Company v The Firestone Tyre & Rubber Company Limited [1972] R.P.C. 457 Warner-Lambert Company LLC v Apotex Pty Limited [2017] FCAFC 58; (2017) 123 IPR 455
Date of hearing: 17 and 20 November 2017
We try to embed the page this law was scraped from. If the site blocks framing, you still get the link and a local excerpt.
Last checked with source on —
Checking whether the official page can be embedded…
Plain-English simplify of this law: a short summary, key points, and both sides of the argument. Generated on first view via Replicate, then cached. Vote on what helps your study.
No study brief is cached for this law yet. Sign up to generate a plain-English brief.
Sign up to generate